{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:33:10Z","timestamp":1777555990566,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ejphar.2008.03.016","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T20:34:08Z","timestamp":1206995648000},"page":"309-316","source":"Crossref","is-referenced-by-count":15,"title":["Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability"],"prefix":"10.1016","volume":"587","author":[{"given":"Riina","family":"Nieminen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katriina","family":"Vuolteenaho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asko","family":"Riutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.03.016_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.addr.2006.01.008","article-title":"Biologics in development for rheumatoid arthritis: relevance to osteoarthritis","volume":"58","author":"Abramson","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2008.03.016_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI119280","article-title":"Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide","volume":"99","author":"Amin","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.03.016_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00002281-199905000-00009","article-title":"Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis","volume":"11","author":"Amin","year":"1999","journal-title":"Curr. Opin. Rheum."},{"key":"10.1016\/j.ejphar.2008.03.016_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/excr.1996.0047","article-title":"Synergistic effects of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation","volume":"222","author":"Berenbaum","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib6","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1158\/1078-0432.CCR-04-0070","article-title":"Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma","volume":"10","author":"Denkert","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/modpathol.3800645","article-title":"Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2","volume":"19","author":"Denkert","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib8","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1074\/jbc.275.16.11750","article-title":"Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3\u2032-untranslated region","volume":"275","author":"Dixon","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1172\/JCI12973","article-title":"Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells","volume":"108","author":"Dixon","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.03.016_bib10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.03.016_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bcp.2004.03.038","article-title":"A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis","volume":"68","author":"Fernandez","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib12","first-page":"827","article-title":"Rheumatoid arthritis and its treatment by gold salts","volume":"20","author":"Forestier","year":"1935","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2008.03.016_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI101235","volume":"20","author":"Freyberg","year":"1941","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.03.016_bib14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.155.2.796","article-title":"Regulation of cyclooxygenase expression in normal human articular chondrocytes","volume":"155","author":"Geng","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/ard.31.4.308","article-title":"Clinical response and serum gold levels in chrysotherapy. Lack of correlation","volume":"31","author":"Gerber","year":"1972","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2008.03.016_bib16","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.blo.0000144484.69656.e4","article-title":"The regulation of chondrocyte function by proinflammatory mediators","volume":"427S","author":"Goldring","year":"2004","journal-title":"Clin. Orthop. Rel. Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1006\/scdb.1997.0183","article-title":"The role of elav-like genes, a conserved family encoding RNA-binding proteins, in growth and development","volume":"8","author":"Good","year":"1997","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib18","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/sj.ki.5000323","article-title":"Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells","volume":"69","author":"Harding","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.03.016_bib19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/art.10356","article-title":"Cyclooxygenase-2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants","volume":"46","author":"Hardy","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2008.03.016_bib20","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1073\/pnas.0506620102","article-title":"Divergent responses of chondrocytes and endothelial cells to shear stress: cross-talk among COX-2, the phase 2 response, and apoptosis","volume":"102","author":"Healy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2008.03.016_bib21","series-title":"The Eicosanoids","first-page":"43","article-title":"Regulation and function of prostaglandin synthase 2\/cyclooxygenase II","author":"Herschman","year":"2004"},{"key":"10.1016\/j.ejphar.2008.03.016_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejphar.2006.11.060","article-title":"Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR","volume":"558","author":"Jin","year":"2007","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.ejphar.2008.03.016_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.molcel.2005.08.007","article-title":"HuR as a negative posttranscriptional modulator in inflammation","volume":"19","author":"Katsanou","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2008.03.016_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01630483","article-title":"Circulating interleukin-10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report","volume":"44","author":"Lacki","year":"1995","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/MCB.21.3.771-780.2001","article-title":"Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38","volume":"21","author":"Lasa","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.21018","article-title":"A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis","volume":"52","author":"Lehman","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2008.03.016_bib27","first-page":"162","article-title":"Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes","volume":"6","author":"Loetscher","year":"1994","journal-title":"Effects of anti-rheumatic drugs. Cytokine"},{"key":"10.1016\/j.ejphar.2008.03.016_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03009747709095434","article-title":"Effect of gold treatment on the progression of erosions in RA patients","volume":"6","author":"Luukkainen","year":"1977","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib29","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar1846","article-title":"Differential direct effects of cyclo-oxygenase-1\/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study","volume":"8","author":"Mastbergen","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2008.03.016_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02028298","article-title":"Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro","volume":"24","author":"Moilanen","year":"1988","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2008.03.016_bib31","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1158\/1078-0432.CCR-05-0764","article-title":"Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR","volume":"11","author":"Mrena","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.57.2.88","article-title":"Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study","volume":"57","author":"Munro","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2008.03.016_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(98)00196-9","article-title":"HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues","volume":"92","author":"Nabors","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","article-title":"Arachidonic acid metabolism","volume":"55","author":"Needleman","year":"1986","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1155\/MI.2005.249","article-title":"Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes","volume":"2005","author":"Nieminen","year":"2005","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ejphar.2008.03.016_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.intimp.2006.01.009","article-title":"JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages","volume":"6","author":"Nieminen","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib37","first-page":"127","article-title":"Pharmacology of gold compounds in rheumatoid arthritis","volume":"4","author":"Noriega","year":"1997","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.45.12.996","article-title":"Collagenase production by human mononuclear cells in culture: inhibition by gold containing compounds and other antirheumatic agents","volume":"45","author":"Ohta","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2008.03.016_bib39","first-page":"47","article-title":"Effects of gold compounds on leukotriene B4, leukotriene C4 and prostaglandin E2 production by polymorphonuclear leukocytes","volume":"13","author":"Parente","year":"1986","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1006\/bbrc.1999.1413","article-title":"Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor kappa B","volume":"263","author":"Pistritto","year":"1999","journal-title":"Biochem. Biophys. Res. Co."},{"key":"10.1016\/j.ejphar.2008.03.016_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bj3180325","article-title":"Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation","volume":"318","author":"Ristim\u00e4ki","year":"1996","journal-title":"Biochem. J"},{"key":"10.1016\/j.ejphar.2008.03.016_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.58.5.281","article-title":"Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate","volume":"58","author":"Sander","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2008.03.016_bib43","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1074\/jbc.M300016200","article-title":"Tristetraprolin binds to the 3\u2032-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site","volume":"278","author":"Sawaoka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00274936","article-title":"Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate","volume":"12","author":"Seitz","year":"1992","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ejphar.2008.03.016_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/B:JOCI.0000010424.41475.17","article-title":"Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms","volume":"23","author":"Seitz","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib46","doi-asserted-by":"crossref","first-page":"25227","DOI":"10.1074\/jbc.M301813200","article-title":"The RNA-binding protein HuR regulates the expression of cyclooxygenase-2","volume":"278","author":"Sengupta","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.1780360211","article-title":"Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells","volume":"36","author":"Sfikakis","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2008.03.016_bib48","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1074\/jbc.275.9.6628","article-title":"Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA","volume":"275","author":"Sheng","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human synovial tissue: differential elevation of cyclooxygenase-2 in inflammatory joint diseases","volume":"41","author":"Siegle","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2008.03.016_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tiv.2004.11.001","article-title":"Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion","volume":"19","author":"Stern","year":"2005","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejphar.2008.03.016_bib51","doi-asserted-by":"crossref","first-page":"37637","DOI":"10.1074\/jbc.M301481200","article-title":"Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR","volume":"278","author":"Subbaramaiah","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib52","doi-asserted-by":"crossref","first-page":"32393","DOI":"10.1074\/jbc.M402059200","article-title":"The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself","volume":"279","author":"Tchen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib53","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1074\/jbc.M512722200","article-title":"Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells","volume":"281","author":"Thiel","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.03.016_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.53.082901.103952","article-title":"Cyclooxygenase-2: a therapeutic target","volume":"53","author":"Turini","year":"2002","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.ejphar.2008.03.016_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/joca.2002.0855","article-title":"Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage","volume":"10","author":"van Beuningen","year":"2002","journal-title":"Osteoarthr. Cartilage"},{"key":"10.1016\/j.ejphar.2008.03.016_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Ann. Rev. Pharm. Tox."},{"key":"10.1016\/j.ejphar.2008.03.016_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jbmr.5650020304","article-title":"Comparison of the effects of auranofin, gold sodium thiomalate, and penicillamine on resorption of cultured fetal rat long bones","volume":"2","author":"Vargas","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2008.03.016_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/03009740510026797","article-title":"Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage","volume":"34","author":"Vuolteenaho","year":"2005","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2008.03.016_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","article-title":"Biologic actions and pharmacokinetic studies of auranofin","volume":"75","author":"Walz","year":"1983","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2008.03.016_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1568010033484142","article-title":"Effects of chrisotherapeutic gold compounds on prostaglandin E2 production","volume":"2","author":"Yamashita","year":"2003","journal-title":"Current Drug Targets \u2013 Inflamm. Allergy"},{"key":"10.1016\/j.ejphar.2008.03.016_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.53.5.315","article-title":"Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane","volume":"53","author":"Yanni","year":"1994","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2008.03.016_bib62","doi-asserted-by":"crossref","first-page":"11167","DOI":"10.1074\/jbc.M211424200","article-title":"Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908003427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908003427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T10:41:14Z","timestamp":1684320074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908003427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":62,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0014299908003427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.03.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}